IL-4/IL-13 signaling beyond JAK/STAT

Journal of Allergy and Clinical Immunology

Volumn 105, Issue 6 II, 2000, Pages 1063-1070

  Jiang, Hong ^a   Harris, Miera B ^a   Rothman, Paul ^a,b  

^a College of Physicians and Surgeons ^*  (United States)

^b Och Spine at New York Presbyterian Hospitals   (United States)

Author keywords

BCL 6; Cell signaling; Dok; Fes; IL 13; IL 4; Interleukins; IRS; SOCS; Transcription factor

Indexed keywords

INTERLEUKIN 13; INTERLEUKIN 4;

ALLERGY; ARTICLE; CELL PROLIFERATION; GENE INDUCTION; HUMAN; IMMUNE RESPONSE; PRIORITY JOURNAL; SIGNAL TRANSDUCTION;

EID: 0033945403     PISSN: 00916749     EISSN: None     Source Type: Journal    
DOI: 10.1067/mai.2000.107604     Document Type: Article

References (89)

1. Callard RE, Matthews DJ, Hibbert L. IL-4 and IL-13 receptors: Are they one and the same? Immunol Today 1996;17:108-10.
2. Nelms K, Keegan AD, Zamorano J, Ryan JJ, Paul WE. The IL-4 receptor: signaling mechanisms and biologic functions. Annu Rev Immunol 1999;17:701-38.
3. de Vries JE. Molecular and biological characteristics of interleukin-13. Chem Immunol 1996;63:204-18.
4. Huang JT, Welch JS, Ricote M, et al. Interleukin-4-dependent production of PPAR-gamma ligands in macrophages by 12/15-lipoxygenase. Nature 1999;400:378-82.
5. Thompson K, Wright S, Sheron N. Chemotactic and suppressor cytokine networks. Hepatogastroenterology 1996;43:15-31.
6. Galizzi JP, Zuber CE, Harada N, et al. Molecular cloning of a cDNA encoding the human interleukin 4 receptor. Int Immunol 1990;2:669-75.
7. Hilton DJ, Zhang JG, Metcalf D, Alexander WS, Nicola NA, Willson TA. Cloning and characterization of a binding subunit of the interleukin 13 receptor that is also a component of the interleukin 4 receptor. Proc Natl Acad Sci U S A 1996;93:497-501.
8. Aman MJ, Tayebi N, Obiri NI, Puri RK, Modi WS, Leonard WJ. cDNA cloning and characterization of the human interleukin 13 receptor alpha chain. J Biol Chem 1996;271:29265-70.
9. Donaldson DD, Whitters MJ, Fitz LJ, et al. The murine IL-13 receptor alpha 2: molecular cloning, characterization, and comparison with murine IL-13 receptor alpha 1. J Immunol 1998;161:2317-24.
10. Hage T, Sebald W, Reinemer P. Crystal structure of the interleukin4/receptor alpha chain complex reveals a mosaic binding interface. Cell 1999;97:271-81.
11. Tony HP, Shen BJ, Reusch P, Sebald W. Design of human interleukin-4 antagonists inhibiting interleukin-4-dependent and interleukin-13-dependent responses in T-cells and B-cells with high efficiency. Eur J Biochem 1994;225:659-65.
12. Zurawski SM, Chomarat P, Djossou O, et al. The primary binding subunit of the human interleukin-4 receptor is also a component of the interleukin-13 receptor. J Biol Chem 1995;270:13869-78.
13. Urban JF Jr, Noben-Trauth N, Donaldson DD, et al. IL-13, IL-4Ralpha, and Stato are required for the expulsion of the gastrointestinal nematode parasite Nippostrongylus brasiliensis. Immunity 1998;8:255-64.
14. Taylor N, Candotti F, Smith S, et al. Interleukin-4 signaling in B lymphocytes from patients with X-linked severe combined immunodeficiency. J Biol Chem 1997;272:7314-9.
15. Reichel M, Nelson BH, Greenberg PD, Rothman PB. The IL-4 receptor alpha-chain cytoplasmic domain is sufficient for activation of JAK-1 and STAT6 and the induction of IL-4-specific gene expression. J Immunol 1997;158:5860-7.
16. Murata T, Taguchi J, Puri RK. Interleukin-13 receptor alpha' but not alpha chain: a functional component of interleukin-4 receptors. Blood 1998;91:3884-91.
17. Miyazaki T, Kawahara A, Fujii H, et al. Functional activation of Jakl and Jak3 by selective association with IL-2 receptor subunits. Science 1994;266:1045-7.
18. Russell SM, Johnston JA, Noguchi M, et al. Interaction of IL-2R beta and gamma c chains with Jakl and Jak3: implications for XSCID and XCID. Science 1994;266:1042-5.
19. Welham MJ, Learmonth L, Bone H, Schrader JW. Interleukin-13 signal transduction in lymphohemopoietic cells. Similarities and differences in signal transduction with interleukin-4 and insulin. J Biol Chem 1995;270:12286-96.
20. Roy B, Cathcart MK. Induction of 15-lipoxygenase expression by IL-13 requires tyrosine phosphorylation of Jak2 and Tyk2 in human monocytes. J Biol Chem 1998;273:32023-9.
21. Murata T, Puri RK. Comparison of IL-13- and IL-4-induced signaling in EBV-immortalized human B cells. Cell Immunol 1997;175:33-40.
22. Sun XJ, Rothenberg P, Kahn CR, et al. Structure of the insulin receptor substrate IRS-1 defines a unique signal transduction protein. Nature 1991;352:73-7.
23. White MF. The IRS-signaling system: a network of docking proteins that mediate insulin and cytokine action. Recent Prog Horm Res 1998;53:119-38.
24. SunXJ, WangLM,ZhangY, et al. Role of IRS-2 in insulin and cytokine signalling. Nature 1995;377:173-7.
25. Wang LM, Myers MG Jr, Sun XJ, Aaronson SA, White M, Pierce JH. 1RS-1 : essential for insulin- and IL-4-stimulated mitogenesis in hematopoietic cells. Science 1993;261:1591-4.
26. White MF, Livingston JN, Backer JM, et al. Mutation of the insulin receptor at tyrosine 960 inhibits signal transmission but does not affect its tyrosine kinase activity. Cell 1988;54:641-9.
27. Keegan AD, Nelms K, White M, Wang LM, Pierce JH, Paul WE. An IL-4 receptor region containing an insulin receptor motif is important for IL4-mediated IRS-1 phosphorylation and cell growth. Cell 1994;76:811-20.
28. Downward J. Mechanisms and consequences of activation of protein kinase B/Akt. Curr Opin Cell Biol 1998;10:262-7.
29. Alessi DR, Kozlowski MT, Weng QP, Morrice N, Avruch J. 3-Phosphoinositide-dependent protein kinase l (PDK1) phosphorylates and activates the p70 S6 kinase in vivo and in vitro. Curr Biol 1998;8:69-81.
30. Zamorano J, Wang HY, Wang LM, Pierce JH, Keegan AD. IL-4 protects cells from apoptosis via the insulin receptor substrate pathway and a second independent signaling pathway. J Immunol 1996;157:4926-34.
31. Nunez G, del Peso L. Linking extracellular survival signals and the apoptotic machinery. Curr Opin Neurobiol 1998;8:613-8.
32. Scheid MP, Duronio V. Dissociation of cytokine-induced phosphorylation of Bad and activation of PKB/akt: involvement of MEK upstream of Bad phosphorylation. Proc Natl Acad Sci U S A 1998;95:7439-44.
33. Nelms K, Snow AL, Hu-Li J, Paul WE. FRIP, a hematopoietic cell-specific rasGAP-interacting protein phosphorylated in response to cytokine stimulation. Immunity 1998;9:13-24.
34. Di Cristofano A, Carpino N, Dunant N, et al. Molecular cloning and characterization of p56dok-2 defines a new family of RasGAP-binding proteins. J Biol Chem 1998;273:4827-30.
35. Carpino N, Wisniewski D, Strife A, et al. p62(dok): a con sti tu lively tyrosine-phosphorylated, GAP-associated protein in chronic myelogenous leukemia progenitor cells. Cell 1997;88:197-204.
36. Yamanashi Y, Baltimore D. Identification of the Abl- and rasGAP-associated 62 kDa protein as a docking protein, Dok. Cell 1997;88:205-11.
37. Haque SJ, Wu Q, Kammer W, et al. Receptor-associated constitutive protein tyrosine phosphatase activity controls the kinase function of JAKL Proc Natl Acad Sci U S A 1997;94:8563-8.
38. Scharenberg AM, Kinet JP The emerging field of receptor-mediated inhibitory signaling: SHP or SHIP? Cell 1996;87:961-4.
39. Haque SJ, Harbor P, Tabrizi M, Yi T, Williams BR. Protein-tyrosine phosphatase Shp-1 is a negative regulator of IL-4- and IL-13-dependent signal transduction. J Biol Chem 1998;273:33893-6.
40. GadinaM, Stancato LM, Bacon CM, Larner AC, O'SheaJJ. Involvement of SHP-2 in multiple aspects of IL-2 signaling: evidence for a positive regulatory role. J Immunol 1998;160:4657-61.
41. Kuhne MR, Pawson T, Lienhard GE, Feng GS. The insulin receptor substrate 1 associates with the SH2-containing phosphotyrosine phosphatase Syp. J Biol Chem 1993;268:11479-81.
42. Imani F, Rager KJ, Catipovic B, Marsh DG. Interleukin-4 (IL-4) induces phosphatidylinositol 3-kinase (p85) dephosphorylation. Implications for the role of SHP-1 in the IL-4-induced signals in human B cells. J Biol Chem 1997;272:7927-31.
43. D'Ambrosio D, Hippen KL, Minskoff SA, et al. Recruitment and activation of PTP1C in negative regulation of antigen receptor signaling by Fc gamma RUB 1. Science 1995;268:293-7.
44. Burshtyn DN, Scharenberg AM, Wagtmann N, et al. Recruitment of tyrosine phosphatase HCP by the killer cell inhibitor receptor. Immunity 1996;4:77-85.
45. Muta T, Kurosaki T, Misulovin Z, Sanchez M, Nussenzweig MC, Ravetch JV. A 13-amino-acid motif in the cytoplasmic domain of Fc gamma RUB modulates B-cell receptor signalling. Nature 1994;369:340.
46. Daeron M, Latour S, Malbec O, et al. The same tyrosine-based inhibition motif, in the intracytoplasmic domain of Fc gamma RUB, regulates negatively BCR-, TCR-, and FcR-dependent cell activation. Immunity 1995;3:635-46.
47. Hershey GK, Friedrich MF, Esswein LA, Thomas ML, Chatila TA. The association of atopy with a gain-of-function mutation in the alpha subunit of the interleukin-4 receptor. N Engl J Med 1997;337:1720-5.
48. Zamorano J, Keegan AD. Regulation of apoptosis by tyrosine-containing domains of IL-4R alpha: Y497 and Y713, but not the STAT6-docking tyrosines, signal protection from apoptosis. J Immunol 1998; 161:859-67.
49. Giallourakis C, Kashiwada M, Pan P, et al. Positive regulation of IL-4 mediated proliferation by the SH2-containing inositol 5'-phosphatase (SHIP). J Biol Chem. In press, 2000.
50. Damen JE, Liu L, Rosten P, et al. The 145-kDa protein induced to associate with She by multiple cytokines is an inositol tetraphosphate and phosphaudylinositol 3,4,5- triphosphate 5-phosphatase. Proc Natl Acad Sci USA 1996;93:1689-93.
51. Durstin M, Inhorn RC, Griffin JD. Tyrosine phosphorylation of She is not required for proliferation or viability signaling by granulocytemacrophage colony-stimulating factor in hematopoietic cell lines. J Immunol 1996;157:534-40.
52. Liu L, Damen JE, Hughes MR, Babic I, Jirik FR, Krystal G. The Src homology 2 (SH2) domain of SH2-containing inositol phosphatase (SHIP) is essential for tyrosine phosphorylation of SHIP, its association with She, and its induction of apoptosis. J Biol Chem 1997;272:8983-8.
53. Lioubin MN, Algate PA, Tsai S, Carlberg K, Aebersold A, Rohrschneider LR. p150Ship, a signal transduction molecule with inositol polyphosphate-5-phosphatase activity. Genes Dev 1996;10:1084-95.
54. Ware MD, Rosten P, Damen JE, Liu L, Humphries RK, Krystal G. Cloning and characterization of human SHIP, the 145-kD inositol 5phosphatase that associates with SHC after cytokine stimulation. Blood 1996;88:2833-40.
55. Franke TF, Kaplan DR, Cantley LC, Toker A. Direct regulation of the Akt proto-oncogene product by phosphatidylinositol-3,4-bisphosphate. Science 1997;275:665-8.
56. Helgason CD, Kalberer CP, Damen JE, et al. A dual role for src homology 2 domain-containing inositol-5-phosphatase (SHIP) in immunity. Aberrant development and enhanced function of b lymphocytes in SHIP(-/)- mice. J Exp Med 2000;191:781-94.
57. Bardwell VJ, Treisman R. The POZ domain: a conserved protein-protein interaction motif. Genes Dev 1994;8:1664-77.
58. Chardin P, Courtois G, Mattei MG, Gisselbrecht S. The KUP gene, located on human chromosome 14, encodes a protein with two distant zinc fingers. Nucleic Acids Res 1991;19:1431-6.
59. Chen Z, Brand NJ, Chen A, et al. Fusion between a novel Kruppel-like zinc finger gene and the retinoic acid receptor-alpha locus due to a variant t(l 1;17) translocation associated with acute promyelocytic leukaemia. EMBO J 1993;12:1161-7.
60. DiBello PR, Withers DA, Bayer CA, Fristrom JW, Guild GM. The Drosophila Broad-Complex encodes a family of related proteins containing zinc fingers. Genetics 1991;129:385-97.
61. Numoto M, Niwa O, Kaplan J, et al. Transcriptional represser ZF5 identifies a new conserved domain in zinc finger proteins. Nucleic Acids Res 1993;21:3767-75.
62. Zollman S, Godt D, Prive GG, Couderc JL, Laski FA. The BTB domain, found primarily in zinc finger proteins, defines an evolutionary conserved family that includes several developmentally regulated genes in Drosophila. Proc Natl Acad Sci U S A 1994;91:10717-21.
63. Chang CC, Ye BH, Chaganti RS, Dalla-Favera R. BCL-6, a POZ/zinc-finger protein, is a sequence-specific transcriptional repressor. Proc Natl Acad Sci USA 1996;93:6947-52.
64. Dhordain P, Albagli O, Lin RJ, et al. Corepressor SMRT binds the BTB/POZ repressing domain of the LAZ3/BCL6 oncoprotein. Proc Natl Acad Sci U S A 1997;94:10762-7.
65. Seyfert VL, Allman D, He Y, Staudt LM. Transcriptional repression by the proto-oncogene BCL-6. Oncogene 1996;12:2331-42.
66. Kerckaert JP, Deweindt C, Tilly H, Quief S, Lecocq G, Bastard C. LAZ3, a novel zinc-finger encoding gene, is disrupted by recurring chromosome 3q27 translocations in human lymphomas. Nat Genet 1993;5:66-70.
67. Miki T, Kawamata N, Hirosawa S, Aoki N. Gene involved in the 3q27 translocation associated with B-cell lymphoma, BCL5, encodes a Kruppel-like zinc-finger protein. Blood 1994;83:26-32.
68. Ye BH, Rao PH, Chaganti RS, Dalla-Favera R. Cloning of bcl-6, the locus involved in chromosome translocations affecting band 3q27 in Bcell lymphoma. Cancer Res 1993;53:2732-5.
69. Baron BW, Nucifora G, McCabe N, Espinosa RD, Le Beau MM, McKeithan TW. Identification of the gene associated with the recurring chromosomal translocations t(3;14)(q27;q32) and t(3;22)(q27;ql 1) in B-cell lymphomas. Proc Natl Acad Sci U S A 1993;90:5262-6.
70. Dent AL, Shaffer AL, Yu X, Allman D, Staudt LM. Control of inflammation, cytokine expression, and germinal center formation by BCL-6. Science 1997;276:589-92.
71. Harris MB, Chang CC, Berton MT, et al. Transcriptional repression of Stato-dependent interleukin-4-induced genes by BCL-6: specific regulation of iepsilon transcription and immunoglobulin E switching. Mol Cell Biol 1999;19:7264-75.
72. Cattoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood 1995;86:45-53.
73. Flenghi L, Ye BH, Fizzotti M, et al. A specific monoclonal antibody (PG-B6) detects expression of the BCL-6 protein in germinal center B cells. AmJPathol 1995;147:405-11.
74. Onizuka T, Moriyama M, Yamochi T, et al. BCL-6 gene product, a 92- to 98-kD nuclear phosphoprotein, is highly expressed in germinal center B cells and their neoplastic counterparts. Blood 1995;86:28-37.
75. Ye BH, Cattoretti G, Shen Q, et al. The BCL-6 proto-oncogene controls germinal-centre formation and Th2-type inflammation. Nat Genet 1997;16:161-70.
76. Dent AL, Doherty TM, Paul WE, Sher A, Staudt LM. BCL-6-deficient mice reveal an IL-4-independent, STAT6-dependent pathway that con-trols susceptibility to infection by Leishmania major. J Immunol 1999;163:2098-103.
77. Dent AL, Hu-Li J, Paul WE, Staudt LM. T helper type 2 inflammatory disease in the absence of interleukin 4 and transcription factor STAT6. Proc Natl Acad Sci U S A 1998;95:13823-8.
78. Endo TA, Masuhara M, Yokouchi M, et al. A new protein containing an SH2 domain that inhibits JAK kinases. Nature 1997;387:921-4.
79. Naka T, Narazaki M, Hirata M, et al. Structure and function of a new STAT-induced STAT inhibitor. Nature 1997;387:924-9.
80. Starr R, Willson TA, Viney EM, et al. A family of cytokine-inducible inhibitors of signalling. Nature 1997;387:917-21.
81. Hilton DJ, Richardson RT, Alexander WS, et al. Twenty proteins containing a C-terminal SOCS box form five structural classes. Proc Natl Acad Sci US A 1998;95:114-9.
82. Narazaki M, Fujimoto M, Matsumoto T, et al. Three distinct domains of SSI-1/SOCS-l/JAB protein are required forits suppression of interleukin 6 signaling. Proc Natl Acad Sci U S A 1998;95:13130-4.
83. Nicholson SE, Willson TA, Farley A, et al. Mutational analyses of the SOCS proteins suggest a dual domain requirement but distinct mechanisms for inhibition of LIE and IL-6 signal transduction. EMBO J 1999;18:375-85.
84. Yasukawa H, Misawa H, Sakamoto H, et al. The JAK-binding protein JAB inhibits Janus tyrosine kinase activity through binding in the activation loop. EMBO J 1999;18:1309-20.
85. Losman JA, Chen XP, Hilton D, Rothman P. Cutting edge: SOCS-1 is a potent inhibitor of IL-4 signal transduction. J Immunol 1999;162: 3770-4.
86. Dickensheets HL, Venkataraman C, Schindler U, Donnelly RP. Interferons inhibit activation of STAT6 by interleukin 4 in human monocytes by inducing SOCS-1 gene expression. Proc Natl Acad Sci U S A 1999;96:10800-5.
87. Venkataraman C, Leung S, Salvekar A, Mano H, Schindler U. Repression of IL-4-induced gene expression by IFN-gamma requires Statl activation. J Immunol 1999;162:4053-61.
88. Naka T, Matsumoto T, Narazaki M, et al. Accelerated apoptosis of lymphocytes by augmented induction of Bax in SSI-1 (STAT-induced STAT inhibitor-1) deficient mice. Proc Natl Acad Sci U S A 1998;95:15577-82.
89. Starr R, Metcalf D, Elefanty AG, et al. Liver degeneration and lymphoid deficiencies in mice lacking suppressor of cytokine signaling-1. Proc Natl Acad Sci U S A 1998;95:14395-9.